Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | RVMD | GMAB | ||
| Company | Incyte Corp | Revolution Medicines Inc | Genmab A/S ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 92.28 | 93.17 | 26.16 | ||
| High | 92.50 | 95.31 | 26.47 | ||
| Low | 90.20 | 92.09 | 25.78 | ||
| Latest | 90.30 | 92.51 | 25.82 | ||
| Change | -1.96 | -0.70 | -0.21 | ||
| % Change | -2.12% | -0.75% | -0.81% | ||
| Volume | 1,494,300 | 1,102,800 | 1,816,100 | ||
| 20-Day Average Volume | 1,675,880 | 1,875,750 | 1,698,125 | ||
| Previous Close | 92.26 | 93.21 | 26.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 94.08 | 97.65 | 26.72 | ||
| 20-Day Raw Stochastic | 8.94% | 4.09% | 17.74% | ||
| 20-Day Relative Strength | 37.65 | 41.85 | 36.58 | ||
| Weighted Alpha | +36.07 | +93.14 | +16.46 | ||
| Today's Opinion | 24% Sell | 40% Buy | 72% Sell | ||
| Previous Opinion | 24% Sell | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 48% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.53% since 03/20/26 | -3.41% since 03/20/26 | +2.87% since 03/20/26 | ||
| Low | 89.25 on 03/24/26 | 92.09 on 03/27/26 | 25.42 on 03/24/26 | ||
| High | 93.83 on 03/25/26 | 98.80 on 03/23/26 | 26.47 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -10.83% since 02/27/26 | -9.32% since 02/27/26 | -12.30% since 02/27/26 | ||
| Low | 89.25 on 03/24/26 | 92.09 on 03/27/26 | 24.95 on 03/20/26 | ||
| High | 101.00 on 03/02/26 | 102.36 on 03/03/26 | 29.85 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -9.80% since 12/26/25 | +14.56% since 12/26/25 | -22.74% since 12/26/25 | ||
| Low | 89.25 on 03/24/26 | 76.28 on 01/05/26 | 24.95 on 03/20/26 | ||
| High | 112.29 on 01/07/26 | 124.49 on 01/16/26 | 35.43 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +9.19% since 09/26/25 | +110.63% since 09/26/25 | -11.18% since 09/26/25 | ||
| Low | 82.52 on 09/29/25 | 44.05 on 09/29/25 | 24.95 on 03/20/26 | ||
| High | 112.29 on 01/07/26 | 124.49 on 01/16/26 | 35.43 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,361,032 | 18,471,704 | 16,724,459 | ||
| Shares Outstanding, K | 199,014 | 198,173 | 642,507 | ||
| Annual Sales | 5,141,240,000 | 0 | 3,720,000,000 | ||
| Annual Net Income | 1,286,650,000 | -1,131,300,000 | 963,000,000 | ||
| Last Quarter Sales | 1,506,840,000 | 0 | 1,058,000,000 | ||
| Last Quarter Net Income | 299,280,000 | -364,890,000 | 31,000,000 | ||
| 60-Month Beta | 0.84 | 0.99 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.80 on 02/10/26 | -1.86 on 02/25/26 | 0.05 on 02/17/26 | ||
| Latest Earnings Date | 05/05/26 | 05/06/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.93 | 0.00 | 16.85 | ||